The Michael J. Fox Foundation (MJFF) is today announcing the launch of four new funding programs focused on driving forward research toward transformative treatments and a cure for Parkinson’s disease (PD).
The new funding opportunities are open to both academic and industry researchers. Projects should promote PD drug development around the most promising therapeutic pathways and targets, including programs dedicated to leading genetic targets alpha-synuclein and LRRK2.
Researchers can also apply for access to MJFF’s growing inventory of tissue samples from pre-clinical models and clinical populations for projects seeking to address promising Parkinson’s ideas.
In addition to the four launching programs, four other rolling programs are currently open to researchers, and accepting applications. Check out the complete list and apply for funding at https://www.michaeljfox.org/research/apply-for-grant.html.